No Video/Audio Available.

SomnoMed announces record September sales
October 18, 2016 11:35 AM

SomnoMed Ltd (ASX:SOM) has announced that it achieved record September sales, which were 23.8% higher compared to the same period last year.

The company says this compensated for the usually soft Northern summer months of July and August (which saw 13% growth year on year). This resulted in unit sale growth rates of 16.9% for the first quarter of the 2016 financial year.

SomnoMed also says total revenues were up 13.4% for the quarter to $10.94 million.

The company says sales of its SomnoDent devices dominated American sales, accounting for 56% of direct sales.

SomnoMed posted a net profit of $67,000 at 30 June 2016.

Comment on this story
Full Name:
Type the characters you see in the picture below.
Letters are not case-sensitive

Latest Finance News


Company News